Document:

EX-10.58

 Exhibit 10.58 
  

 
 2 August, 2017 

Nicholas J. Sarlis, MD, PhD 
 8 Devonshire Ct. 

Greenville, DE 19807 
 RE:    Retention
Agreement 
 Dear Dr. Sarlis, 
 You are an important
part of SELLAS Life Sciences Group Ltd (the “Company”), and we recognize that your engagement and commitment are critical to the Company’s success. We value the contributions you make to our organization and are pleased to
offer you the opportunity to earn Retention Bonus (as defined and described below) upon and subject to the terms and conditions of this Retention Agreement (the “Retention Agreement”). 

As an incentive for you to continue to contribute your efforts, talents and services to the Company, you will be eligible to earn a retention bonus in the
amount set forth on Schedule 1 hereof, less applicable withholdings and deductions, which shall be determined based on the amount of the Aggregate Consideration received in a Strategic Transaction involving the Company (the “Retention
Bonus”). 
 If and to the extent that (x) any Contingent Consideration is actually paid to the Company and/or its securityholders with respect
to a Strategic Transaction, (y) including such Contingent Consideration within Aggregate Consideration would have resulted in the payment of a higher Retention Bonus under Schedule 1, and (z) any payment contingent upon payment of such
Contingent Consideration would be deemed to be subject to a substantial risk of forfeiture for purposes of Section 409A of the Internal Revenue Code of 1986, as amended, then you shall be eligible to receive an additional bonus (the
“Contingent Retention Bonus”) in an amount equal to (i) the Retention Bonus that would be payable if such Contingent Consideration was included within the Aggregate Consideration paid or payable in connection with the Strategic
Transaction minus (ii) the aggregate amount of any previously paid Retention Bonus and any Contingent Retention Bonus. 
 In addition, if you
are still employed by the Company and make the first introduction of the Strategic Transaction counterparty to the Company (as determined in good faith by the Board), then the amount of the Retention Bonus and any Contingent Retention Bonus payable
hereunder shall be doubled. 
 In order to earn the Retention Bonus (and if applicable, any Contingent Retention Bonus), you must remain actively and
continuously employed by the Company in good standing and on a full-time basis through the consummation of the Strategic Transaction (the date of such consummation, the “CIC Date”) and the CIC Date must occur on or prior to the 18
month anniversary of the effective date of this Retention Agreement. As a further condition to receiving any Retention Bonus (and if applicable, any Contingent Retention Bonus), you must also execute a general release of claims in the form provided
by the Company and allow such release to become effective within 30 days after the Closing. 

  
 1 

 If earned, the Retention Bonus will be paid to you in a lump sum amount, less required payroll withholdings and
deductions, within thirty (30) days following the CIC Date. Any Contingent Retention Bonus shall be paid to you in a lump sum, less required payroll withholdings and deductions, within thirty (30) days following the date that corresponding
Contingent Proceeds are paid to the Company and/or its securityholders, but in no event later than March 15th of the year following the year in which the substantial risk of forfeiture to which such Contingent Retention Bonus was subject lapses.

 Effective upon the closing of the transaction with Galena Biopharma, Inc., this Retention Agreement and all obligations hereunder shall terminate on the
earlier of the eighteen-month anniversary of the date of this Retention Agreement and the date your employment terminates, and upon such termination of this Retention Agreement, this agreement shall be of no further force or effect. 

For purposes of this Retention Agreement: 
 “Strategic
Transaction” shall mean any transaction or series of related transactions entered into by the Company and any counterparty (other than a transaction with Galena Biopharma, Inc.) whereby, directly or indirectly, the Company and any
counterparty effect a business combination involving more than 50% of the capital stock of the Company and/or all or substantially all of its consolidated assets, including, without limitation, (i) a sale, acquisition, purchase or exchange of
stock (including shares issuable upon conversion of any securities convertible into stock) or assets, or (ii) a merger, reverse merger, consolidation, reorganization, scheme of arrangement, tender offer, exchange offer, leveraged buyout or
other extraordinary corporate transaction or business combination; provided, however, that a Strategic Transaction shall not be deemed to include a collaborative, licensing or similar business arrangement, whether now or hereafter existing, between
the Company and a third party in the ordinary course of business in which the Company and the strategic partner continue as independent unaffiliated entities after the consummation of the transaction. 

“Aggregate Consideration” shall mean, with respect to any Strategic Transaction, an amount equal to the aggregate value of cash and/or
property (e.g., securities, notes, etc.) paid or payable to the Company or the Company’s stockholders in connection with a Strategic Transaction (all as determined expenses and by the Board in good faith). For the avoidance of doubt,
Transaction Proceeds are net of all costs, fees, disbursements incurred by or on behalf of the Company in connection with such Strategic Transaction, including, without limitation, legal, accounting, brokerage and banking costs, fees, expenses and
disbursements. Aggregate Consideration shall include an estimate of the present value of any amounts payable to the Company or the Company’s securityholders in connection with the Strategic Transaction that are either held in an escrow fund or
otherwise held back for indemnification or other claims, but shall not include the value of any Contingent Consideration. In the event that all or part of the consideration paid or payable to the Company or the Company’s securityholders in
connection with a Strategic Transaction is in the form of securities, the Aggregate Consideration shall be deemed to include the fair market value of such securities, determined on the same basis on which such securities were valued in the
transaction. 
 “Contingent Consideration” shall mean any amounts payable to the Company and/or it’s security holders in connection
with a Strategic Transaction that (i) is payable following the closing of a Strategic Transaction and (ii) is contingent upon the performance of the Company or its assets, and/or attainment of financial targets or other performance metrics
following the consummation of the Strategic Transaction. 
 You agree that you will keep the terms and fact of this Retention Agreement completely and
strictly confidential, and that you will not disclose any information concerning this Retention Agreement to anyone other than your professional representatives or immediate family or as required by law. This Retention Agreement does not alter your
status as an at-will employee. 

  
 2 

 This Retention Agreement is the complete, final and exclusive embodiment of the entire agreement between you and
the Company with regard to the Retention Bonus, and it supersedes and replaces any other agreements or undertakings (whether written or unwritten) you may have with the Company concerning any change in control retention payments. The terms of this
Retention Agreement may not be modified or amended in any way except in a written agreement signed by you and a duly authorized officer of the Company. Additionally your employment relationship with the Company remains at will, meaning that either
you or the Company may terminate your employment at any time, with or without cause or advance notice. Nothing in this Retention Agreement is intended to or should be construed to contradict, modify or alter your at will employment or other service
relationship with the Company. 
  

			
	Sincerely,
	
	/s/ Angelos Stergiou
		
	     	 	 Dr. Angelos Stergiou
 Chief Executive
Officer

 ACKNOWLEDGMENT AND ACCEPTANCE 

Agreed to and accepted: 
  

			
	By:	 	    Nicholas J. Sarlis, MD     
	
	    /s/ Nicholas J. Sarlis                

 Date:  2 Aug.
2017                       

  
 3 

 Schedule 1 

- If Aggregate Consideration is $0-$50 Million: Retention Bonus shall be $250,000 

- If Aggregate Consideration is $51-$100 Million: Retention Bonus shall be $500,000 

- If Aggregate Consideration is $101-$150 Million: Retention Bonus shall be $750,000 

- If Aggregate Consideration is $151-$200 Million: Retention Bonus shall be $1,000,000 

- If Aggregate Consideration is $201-$250 Million: Retention Bonus shall be $1,500,000 

- If Aggregate Consideration is in excess of $251 Million: Retention Bonus shall be $1,750,000 

  
 4EX-10.61

 Exhibit 10.61 

SELLAS LIFE SCIENCES GROUP LTD 

STOCK INCENTIVE PLAN #1 

1. Establishment, Purpose and Term of Plan. 

1.1. Establishment. The Sellas Life Sciences Group Ltd Stock Incentive Plan #1 is hereby established effective as of
November 4, 2016 
 1.2. Purpose. The purpose of the Plan is to advance the interests of the Participating
Company Group and its shareholders by providing an incentive to attract, retain and reward persons performing services for the Participating Company Group and by motivating such persons to contribute to the growth and profitability of the
Participating Company Group. 
 1.3. Term of Plan. The Plan shall continue in effect until its termination by the Board; provided,
however, that all Awards shall be granted, if at all, within ten (10) years from the earlier of the date the Plan is adopted by the Board or the date the Plan is duly approved by the shareholders of the Company. 

2. Definitions and Construction. 

2.1. Definitions. Whenever used herein, the following terms shall have their respective meanings set forth below: 

a. “Applicable Laws” means any applicable legal requirements relating to the administration of and the issuance of
securities under equity securities-based compensation plans, including, without limitation, the requirements of the laws of Switzerland, Bermuda, U.S. federal and state securities laws, U.S. federal law, the Code, and the requirements of any stock
exchange or quotation system upon which the securities may then be listed or quoted and the applicable laws of any other country or jurisdiction where Awards are granted under the Plan. For all purposes of this Plan, references to statutes and
regulations shall be deemed to include any successor statutes or regulations, where necessary as determined by the plan administrator, once appointed. 

b. “Award” means an Option or Restricted Stock Unit granted under the Plan. 

c. “Award Agreement” means a written or electronic agreement between the Company and a Participant
setting forth the terms, conditions and restrictions of the Award granted to the Participant. 
 d.
“Board” means the Board of Directors of the Company. If one or more Committees have been appointed by the Board to administer the Plan, “Board” also means such Committee(s).

 e. “Cause” means, unless such term or an equivalent term is otherwise defined with respect to an
Award by the Participant’s Award Agreement or written 

 
contract of employment or service, any of the following: (i) the Participant’s theft, fraud, dishonesty, willful misconduct, breach of fiduciary duty for personal profit, or
falsification of any Participating Company documents or records; (ii) the Participant’s material failure to abide by a Participating Company’s code of conduct or other policies (including, without limitation, policies relating to
confidentiality and reasonable workplace conduct); (iii) the Participant’s unauthorized use, misappropriation, destruction or diversion of any tangible or intangible asset or corporate opportunity of a Participating Company (including,
without limitation, the Participant’s improper use or disclosure of a Participating Company’s confidential or proprietary information); (iv) any intentional act by the Participant which has a material detrimental effect on a
Participating Company’s reputation or business; (v) the Participant’s repeated failure or inability to perform any reasonable assigned duties after written notice from a Participating Company of, and a reasonable opportunity to cure,
such failure or inability; (vi) any material breach by the Participant of any employment or service agreement between the Participant and a Participating Company, which breach is not cured pursuant to the terms of such agreement; or
(vii) the Participant’s conviction (including any plea of guilty or nolo contendere) of any criminal act involving fraud, dishonesty, misappropriation or moral turpitude, or which impairs the Participant’s ability to perform
his or her duties with a Participating Company. 
 f. “Change in Control” means a change in ownership
or control of the Company effected through any of the following transactions: 
 (i) an amalgamation, a merger, consolidation or other
reorganization, unless securities representing more than fifty percent (50%) of the total combined voting power of the voting securities of the amalgamated or successor company are immediately thereafter beneficially owned, directly or indirectly,
by the persons who beneficially owned the Company’s outstanding voting securities immediately prior to such transaction, or 
 (ii) a
sale, transfer or other disposition of all or substantially all of the Company’s assets in liquidation or dissolution of the Company, or 

(iii) the acquisition, directly or indirectly by any person or related group of persons (other than the Company or a person that directly or
indirectly controls, is controlled by, or is under common control with, the Company), of beneficial ownership of securities possessing more than fifty percent (50%) of the total combined voting power of the Company’s outstanding securities
pursuant to a transfer of the then issued and outstanding voting securities of the Company by one or more of the Company’s shareholders. 

Anything in the foregoing to the contrary notwithstanding, a transaction shall not constitute a Change in Control if its sole purpose is to
change the legal jurisdiction of the Company’s incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company’s securities immediately before such transaction. In
addition, a sale by the Company of its securities in a transaction, the primary purpose of which is to raise capital for the Company’s operations and business activities including, without limitation, a qualified public offering, shall not
constitute a Change in Control. 

  
 2 

 g. “Code” means the U.S. Internal Revenue Code of 1986, as
amended, and any applicable regulations and administrative guidelines promulgated thereunder. 
 h.
“Committee” means the compensation committee or other committee or subcommittee of the Board duly appointed to administer the Plan and having such powers as shall be specified by the Board. Unless the powers of
the Committee have been specifically limited, the Committee shall have all of the powers of the Board granted herein, including, without limitation, the power to amend or terminate the Plan at any time, subject to the terms of the Plan and any
applicable limitations imposed by law. 
 i. “Company” means Sellas Life Sciences Group Ltd., a
private company originally formed under the laws of Switzerland and continued into Bermuda as an exempted Company, or any successor corporation thereto. 

j. “Consultant” means any natural person, including an advisor, who is engaged by the Company, or any
Participating Company to render bona fide consulting or advisory services to such entity and who is compensated for the services; provided that the term “Consultant” does not include (i) Employees, (ii) Directors who are paid only a
director’s fee by the Company or who are not compensated by the Company for their services as directors, (iii) securities promoters, (iv) independent agents, franchisees and salespersons who do not have employment relationships with
the Company from which they derive at least fifty percent of their annual income. 
 k. “Director”
means a member of the Board. 
 l. “Disability” means the inability of the Participant, in the
opinion of a qualified physician acceptable to the Company, to perform the major duties of the Participant’s position with the Participating Company Group because of the sickness or injury of the Participant. 

m. “Employee” means any person, including officers, employed by the Company or Participating Company.
Neither service as a Director nor payment of a director’s fee by the Company will be sufficient to constitute “employment” by the Company for purposes of the Plan. 

n. “Exchange Act” means the Securities Exchange Act of 1934, as amended of the United States of
America. 
 o. “Fair Market Value” means, as of any date, the value of a Share or other property as
determined by the Board, in its discretion, or by the Company, in its discretion, if such determination is expressly allocated to the Company herein, subject to the following: 

(i) If, on such date, the Shares are listed on a national or regional securities exchange or market system, the Fair Market Value of a Share
shall be the closing price of a Share as quoted on the national or regional securities exchange or market system constituting the primary market for the Shares, as reported in The Wall Street Journal or such other source as the Company deems
reliable. If the relevant date does not fall on a day on 

  
 3 

 
which the Shares have traded on such securities exchange or market system, the date on which the Fair Market Value shall be established shall be the last day on which the Shares were so traded
prior to the relevant date, or such other appropriate day as shall be determined by the Board, in its discretion. 
 (ii) If, on such date,
the Shares are not listed on a national or regional securities exchange or market system, the Fair Market Value of a Share shall be as determined by the Board in good faith. 

p. “Incentive Stock Option” means an Option intended to be (as set forth in the Award Agreement) and
which qualifies as an incentive stock option within the meaning of Section 422(b) of the Code. 
 q. “Insider
Trading Policy” means the written policy of the Company pertaining to the purchase, sale, transfer or other disposition of the Company’s equity securities by Directors, Officers, Employees or other service providers who may
possess material, nonpublic information regarding the Company or its securities. 
 r. “Nonstatutory Stock
Option” means an Option not intended to be (as set forth in the Award Agreement) or which does not qualify as an Incentive Stock Option. 

s. “Officer” means any person designated by the Board as an officer of the Company. 

t. “Option” means an Incentive Stock Option or a Nonstatutory Stock Option granted pursuant to the
Plan. 
 u. “Parent Corporation” means any corporation or other entity, whether now or hereafter
existing, that controls the Company through the ownership of voting securities, contract or otherwise. 
 v.
“Participant” means any eligible person who has been granted one or more Awards. 
 w.
“Participating Company” means the Company or any Parent Corporation or Subsidiary Corporation. 
 x.
“Participating Company Group” means, at any point in time, all entities collectively which are then Participating Companies. 

y. “Performance Goals” means the goal(s) (or combined goal(s)) determined by the Board in its
discretion to be applicable to a Participant with respect to an Award. As determined by the Board, the Performance Goals applicable to an Award shall provide for a targeted level or levels of achievement using one or more of the following measures:
(a) cash flow, (b) earnings per share, (c) gross revenue, (d) market share, (e) return on capital, (f) total shareholder return, or (g) operating profits. 

  
 4 

 z. “Performance Period” means the time period during which the
Performance Goals or continued status as an Employee, Director, or Consultant must be met as determined by the Committee at is sole discretion. 

aa. “Plan” means this Sellas Life Sciences Group Ltd Stock Incentive Plan #1. 

bb. “Restricted Stock Unit Award” means an Award of a Restricted Stock Unit granted pursuant to
Section 7. 
 cc. “Securities Act” means the U.S. Securities Act of 1933, as amended. 

dd. “Service” means a Participant’s employment or service with the Participating Company Group,
whether in the capacity of an Employee, a Director or a Consultant. Unless otherwise provided by the Board, a Participant’s Service shall not be deemed to have terminated merely because of a change in the capacity in which the Participant
renders such Service or a change in the Participating Company for which the Participant renders such Service, provided that there is no interruption or termination of the Participant’s Service. Furthermore, a Participant’s Service shall
not be deemed to have terminated if the Participant takes any military leave, sick leave, or other bona fide leave of absence approved by the Company. However, unless otherwise provided by the Board, if any such leave taken by a Participant exceeds
ninety (90) days, then on the ninety-first (91st) day following the commencement of such leave the Participant’s Service shall be deemed to have terminated, unless the Participant’s right to return to Service is guaranteed by statute
or contract. Notwithstanding the foregoing, unless otherwise designated by the Company or required by law, an unpaid leave of absence shall not be treated as Service for purposes of determining vesting under the Participant’s Award Agreement.
Except as otherwise provided by the Board, in its discretion, the Participant’s Service shall be deemed to have terminated either upon an actual termination of Service or upon the business entity for which the Participant performs Service
ceasing to be a Participating Company. Subject to the foregoing, the Company, in its discretion, shall determine whether the Participant’s Service has terminated and the effective date of and reason for such termination. 

ee. “Share” means a common share of par value $10.00 each of the Company, as adjusted from time to time
in accordance with Section 4.1. 
 ff. “Subsidiary Corporation” means any corporation or other
entity, whether now or hereafter existing, that is controlled by the Company through ownership of voting securities, contract or otherwise. 

gg. “Ten Percent Shareholder” means a person who, at the time an Award is granted to such person, owns
shares possessing more than ten percent (10%) of the total combined voting power of all classes of shares of a Participating Company within the meaning of Section 422(b)(6) of the Code. 

hh. “Vesting Conditions” mean those conditions established in accordance with the Plan prior to the
satisfaction of which shares subject to an Award remain 

  
 5 

 
subject to forfeiture or a repurchase option in favor of the Company exercisable for the Participant’s monetary purchase price, if any, for such shares upon the Participant’s
termination of Service. 
 2.2. Construction. Captions and titles contained herein are for convenience only and shall not affect the
meaning or interpretation of any provision of the Plan. Except when otherwise indicated by the context, the singular shall include the plural and the plural shall include the singular. Use of the term “or” is not intended to be exclusive,
unless the context clearly requires otherwise. 
 3. Administration. 

3.1. Administration by the Board. The Plan shall be administered by the Board. All questions of interpretation of the Plan, of any
Award Agreement or of any other form of agreement or other document employed by the Company in the administration of the Plan or of any Award shall be determined by the Board, and such determinations shall be final, binding and conclusive upon all
persons having an interest in the Plan or such Award, unless fraudulent, dishonest or made in bad faith. Any and all actions, decisions and determinations taken or made by the Board in the exercise of its discretion pursuant to the Plan or Award
Agreement or other agreement thereunder (other than determining questions of interpretation pursuant to the preceding sentence) shall be final, binding and conclusive upon all persons having an interest therein. 

3.2. Authority of Officers. Any Officer shall have the authority to act on behalf of the Company with respect to any matter, right,
obligation, determination or election which is the responsibility of or which is allocated to the Company herein, provided the Officer has apparent authority with respect to such matter, right, obligation, determination or election. 

3.3. Powers of the Board. In addition to any other powers set forth in the Plan and subject to the provisions of
the Plan, the Board shall have the full and final power and authority, in its discretion: 
 a. to determine the persons to whom, and the
time or times at which, Awards shall be granted and the number of Shares to be subject to each Award; 
 b. to determine the type of Award
granted; 
 c. to determine the Fair Market Value of Shares or other property; 

d. to determine the terms, conditions and restrictions applicable to each Award (which need not be identical) and any shares acquired
pursuant thereto, including, without limitation, (i) the exercise or purchase price of shares pursuant to any Award, (ii) the method of payment for shares purchased pursuant to any Award, (iii) the method for satisfaction of any tax
withholding obligation arising in connection with any Award or shares acquired pursuant thereto, including by the withholding or delivery of Shares, (iv) the timing, terms and conditions of the exercisability or vesting of any Award or shares
acquired pursuant thereto, (v) the time of expiration of any Award, (vi) the effect of any Participant’s termination of Service on any of the foregoing, (vii) the performance criteria, if any, and level of achievement

  
 6 

 
versus the performance criteria that shall determine the number of Shares granted, issued, retainable and/or vested, and (vii) all other terms, conditions and restrictions applicable to any
Award or shares acquired pursuant thereto not inconsistent with the terms of the Plan; 
 e. to approve one or more forms of Award
Agreement; 
 f. to amend, modify, extend, cancel or renew any Award or to waive any restrictions or conditions applicable to any Award or
any shares acquired pursuant thereto; 
 g. to accelerate, continue, extend or defer the exercisability or vesting of any Award or any
Shares acquired pursuant thereto, including with respect to the period following a Participant’s termination of Service; 
 h. to
implement a program where (1) outstanding Awards are surrendered or cancelled in exchange for Awards of the same type (which may have lower exercise prices and different terms), Awards of a different type, or cash, or (2) the exercise
price of an outstanding Award is reduced, based in each case on terms and conditions determined by the administrator, once appointed, in its sole discretion; 

i. to allow Participants to satisfy withholding tax obligations or costs attendant to exercising an Award by electing to have the Company
withhold from the Shares or cash to be delivered upon exercise or vesting of an Award that number of Shares represented by the Shares or cash having a Fair Market Value equal to the minimum amount required to be withheld and/or the attendant costs.
The Fair Market Value of any Shares to be withheld will be determined on the date that the amount of tax to be withheld and/or costs imposed is to be determined. All elections by a Participant to have Shares or cash withheld for these purposes will
be made in such form and under such conditions as the Board may deem necessary or advisable; 
 j. to prescribe, amend or rescind rules,
guidelines and policies relating to the Plan, or to adopt sub-plans or supplements to, or alternative versions of, the Plan, including, without limitation, as the Board deems necessary or desirable to comply
with the laws of, or to accommodate the tax policy, accounting principles or custom of, foreign jurisdictions whose citizens may be granted Awards; 

k. to correct any defect, supply any omission or reconcile any inconsistency in the Plan or any Award Agreement and to make all other
determinations and take such other actions with respect to the Plan or any Award as the Board may deem advisable to the extent not inconsistent with the provisions of the Plan or applicable law; and 

l. to make all other determinations deemed necessary or advisable for administering the Plan. 

3.4. Indemnification. In addition to such other rights of indemnification as they may have as members of the Board or as officers or
employees of the Participating Company Group, members of the Board and any officers or employees of the Participating Company Group to whom authority to act for the Board or the Company is delegated shall be indemnified by the Company against all
reasonable expenses, including attorneys’ fees, actually 

  
 7 

 
and necessarily incurred in connection with the defense of any action, suit or proceeding, or in connection with any appeal therein, to which they or any of them may be a party by reason of any
action taken or failure to act under or in connection with the Plan, or any right granted hereunder, and against all amounts paid by them in settlement thereof (provided such settlement is approved by independent legal counsel selected by the
Company) or paid by them in satisfaction of a judgment in any such action, suit or proceeding, except in relation to matters as to which it shall be adjudged in such action, suit or proceeding that such person is liable for fraud, dishonesty, gross
negligence, bad faith or intentional misconduct in duties; provided, however, that within sixty (60) days after the institution of such action, suit or proceeding, such person shall offer to the Company, in writing, the opportunity at its own
expense to handle and defend the same. 
 4. Shares Subject to Plan. 

4.1. Maximum Number of Shares Issuable. Subject to adjustment as provided in Section 4.1, the maximum aggregate number of
Shares that may be issued under the Plan shall be Four Thousand Three Hundred Ten (4,310) Shares and shall consist of authorized but unissued or reacquired Shares or any combination thereof. If an outstanding Award for any reason expires or is
terminated or canceled or if Shares are acquired pursuant to an Award subject to forfeiture or repurchase and are forfeited or repurchased by the Company for an amount not greater than the Participant’s exercise or purchase price, the Shares
allocable to the terminated portion of such Award or such forfeited or repurchased Shares shall again be available for issuance under the Plan. 

4.2. Adjustments for Changes in Capital Structure. Subject to any required action by the shareholders of the
Company and the requirements of Applicable Laws, in the event of any change in the Shares effected without receipt of consideration by the Company, whether through amalgamation, merger, consolidation, reorganization, reincorporation,
recapitalization, reclassification, stock dividend, bonus issue, stock split, share subdivision, reverse stock split, share consolidation, split-up, split-off, spin-off, combination of shares, exchange of shares, or similar change in the capital structure of the Company, or in the event of payment of a dividend or distribution to the shareholders of the Company in a form
other than Shares (excepting normal cash dividends) that has a material effect on the Fair Market Value of Shares, appropriate and proportionate adjustments shall be made in the number and kind of shares subject to the Plan and to any outstanding
Awards, in the ISO Share Limit set forth in Section 5.3, and in the exercise or purchase price per share of any outstanding Awards in order to prevent dilution or enlargement of Participants’ rights under the Plan. For purposes of the
foregoing, conversion of any convertible securities of the Company shall not be treated as “effected without receipt of consideration by the Company.” If a majority of the shares which are of the same class as the shares that are subject
to outstanding Awards are exchanged for, converted into, or otherwise become (whether or not pursuant to an Ownership Change Event) shares of another corporation (the “New Shares”), the Board may unilaterally
amend the outstanding Awards to provide that such Awards are for New Shares. In the event of any such amendment, the number of shares subject to, and the exercise or purchase price per share of, the outstanding Awards shall be adjusted in a fair and
equitable manner as determined by the Board, in its discretion. Any fractional share resulting from an adjustment pursuant to this Section shall be rounded down to the nearest whole number, and the exercise price per share shall be rounded

  
 8 

 
up to the nearest whole cent. In no event may the exercise or purchase price, if any, under any Award be decreased to an amount less than the par value, if any, of the Shares subject to the
Award. Such adjustments shall be determined by the Board, and its determination shall be final, binding and conclusive. 
 5.
Eligibility and Option Limitations. 
 5.1. Persons Eligible for Awards. Awards may be granted
only to Employees, Consultants and Directors. 
 5.2. Participation in the Plan. Awards are granted solely at the discretion
of the Board. Eligible persons may be granted more than one Award. However, eligibility in accordance with this Section shall not entitle any person to be granted an Award, or, having been granted an Award, to be granted an additional Award. 

5.3. Incentive Stock Option Limitations. 

a. Maximum Number of Shares Issuable Pursuant to Incentive Stock Options. Subject to Section 4 and adjustment as provided in
Section 4.1, the maximum aggregate number of Shares that may be issued under the Plan pursuant to the exercise of Incentive Stock Options shall not exceed Four Thousand Three Hundred Ten (4,310) Shares (the “ISO Share
Limit”). The maximum aggregate number of Shares that may be issued under the Plan pursuant to all Awards other than Incentive Stock Options shall be the number of shares determined in accordance with Section 4, subject to
adjustment as provided in Section 4.1. 
 b. Persons Eligible. An Incentive Stock Option may be granted only to a person who,
on the effective date of grant, is an Employee. Any person who is not an Employee on the effective date of the grant of an Option to such person may be granted only a Nonstatutory Stock Option. 

c. Fair Market Value Limitation. To the extent that options designated as Incentive Stock Options (granted under
all stock plans of the Participating Company Group, including the Plan) become exercisable by a Participant for the first time during any calendar year for shares having a Fair Market Value greater than One Hundred Thousand Dollars (US$100,000), the
portions of such options which exceed such amount shall be treated as Nonstatutory Stock Options. For purposes of this Section 5.2, options designated as Incentive Stock Options shall be taken into account in the order in which they were
granted, and the Fair Market Value of Shares shall be determined as of the time the option with respect to such Shares is granted. If the Code is amended to provide for a limitation different from that set forth in this Section, such different
limitation shall be deemed incorporated herein effective as of the date and with respect to such Options as required or permitted by such amendment to the Code. If an Option is treated as an Incentive Stock Option in part and as a Nonstatutory Stock
Option in part by reason of the limitation set forth in this Section, the Participant may designate which portion of such Option the Participant is exercising. In the absence of such designation, the Participant shall be deemed to have exercised the
Incentive Stock Option portion of the Option first. Upon exercise of the Option, Shares issued pursuant to each such portion shall be separately identified. 

  
 9 

 6. Stock Options. 

Options shall be evidenced by Award Agreements specifying the number of Shares covered thereby, in such form as the Board shall from time to
time establish. Award Agreements may incorporate all or any of the terms of the Plan by reference and shall comply with and be subject to the following terms and conditions: 

6.1. Exercise Price. The exercise price for each Option shall be established in the discretion of the Board;
provided, however, that (a) the exercise price per share for an Incentive Stock Option shall be not less than the Fair Market Value of a Share on the effective date of grant of the Option, which shall not be less than the par value of a share
and (b) no Incentive Stock Option granted to a Ten Percent Shareholder shall have an exercise price per share less than one hundred ten percent (110%) of the Fair Market Value of a Share on the effective date of grant of the Option.
Notwithstanding the foregoing, an Incentive Stock Option may be granted with an exercise price lower than the minimum exercise price set forth above if such Incentive Stock Option is granted pursuant to an assumption or substitution for another
option in a manner qualifying under the provisions of Section 424(a) of the Code. 
 6.2. Exercisability and Term of
Options. Options shall be exercisable at such time or times, or upon such event or events, and subject to such terms, conditions, performance criteria and restrictions as shall be determined by the Board and set forth in the
Award Agreement evidencing such Option; provided, however, that (a) no Option shall be exercisable after the expiration of ten (10) years after the effective date of grant of such Option and (b) no Incentive Stock Option granted to a
Ten Percent Shareholder shall be exercisable after the expiration of five (5) years after the effective date of grant of such Option. Subject to the foregoing, unless otherwise specified by the Board in the grant of an Option, any Option
granted hereunder shall terminate ten (10) years after the effective date of grant of the Option, unless earlier terminated in accordance with its provisions. 

6.3. Payment of Exercise Price. 

a. Forms of Consideration Authorized. Except as otherwise provided below, payment of the exercise price for the
number of Shares being purchased pursuant to any Option shall be made (i) in cash, by check or in cash equivalent, (ii) by tender to the Company, or attestation to the ownership, of Shares owned by the Participant having a Fair Market
Value not less than the exercise price, (iii) by delivery of a properly executed notice of exercise together with irrevocable instructions to a broker providing for the assignment to the Company of the proceeds of a sale or loan with respect to
some or all of the shares being acquired upon the exercise of the Option (including, without limitation, through an exercise complying with the provisions of Regulation T as promulgated from time to time by the Board of Governors of the Federal
Reserve System of the United States of America) (a “Cashless Exercise”), (iv) by such other consideration as may be approved by the Board from time to time to the extent permitted by applicable law, or
(v) by any combination thereof. The Board may at any time or from time to time grant Options which do not permit all of the foregoing forms of consideration to be used in payment of the exercise price or which otherwise restrict one or more
forms of consideration. 

  
 10 

 b. Limitations on Forms of Consideration. 

i Tender of Shares. Notwithstanding the foregoing, an Option may not be exercised by tender to the Company, or attestation to the
ownership, of Shares to the extent such tender or attestation would constitute a violation of the provisions of any law, regulation or agreement restricting the redemption of the Company’s Shares. Unless otherwise provided by the Board, an
Option may not be exercised by tender to the Company, or attestation to the ownership, of Shares unless such shares either have been owned by the Participant for more than six (6) months or such other period, if any, required by the Company
(and were not used for another Option exercise by attestation during such period) or were not acquired, directly or indirectly, from the Company. 

ii Cashless Exercise. The Company reserves, at any and all times, the right, in the Company’s sole and absolute discretion, to
establish, decline to approve or terminate any program or procedures for the exercise of Options by means of a Cashless Exercise, including with respect to one or more Participants specified by the Company notwithstanding that such program or
procedures may be available to other Participants. 
 c. Effect of Termination of Service. 

i Option Exercisability. Subject to earlier termination of the Option as otherwise provided by this Plan and unless a longer exercise
period is provided by the Board, an Option shall terminate immediately upon the Participant’s termination of Service to the extent that it is then unvested and shall be exercisable after the Participant’s termination of Service to the
extent it is then vested only during the applicable time period determined in accordance with this Section and thereafter shall terminate. 

ii Disability. If the Participant’s Service terminates because of the Disability of the Participant, the Option, to the extent
unexercised and exercisable for vested shares on the date on which the Participant’s Service terminated, may be exercised by the Participant (or the Participant’s guardian or legal representative) at any time prior to the expiration of
twelve (12) months after the date on which the Participant’s Service terminated, unless a longer exercise period is provided by the Board, but in any event no later than the date of expiration of the Option’s term as set forth in the
Award Agreement evidencing such Option (the “Option Expiration Date”). 
 iii Death. If the
Participant’s Service terminates because of the death of the Participant, the Option, to the extent unexercised and exercisable for vested shares on the date on which the Participant’s Service terminated, may be exercised by the
Participant’s legal representative or other person who acquired the right to exercise the Option by reason of the Participant’s death at any time prior to the expiration of twelve (12) months after the date on which the
Participant’s Service terminated, unless a longer exercise period is provided by the Board, but in any event no later than the Option Expiration Date. The Participant’s Service shall be deemed to have terminated on account of death if the
Participant dies within three (3) months after the Participant’s termination of Service. 

  
 11 

 iv Termination for Cause. Notwithstanding any other provision of the Plan to the
contrary, if the Participant’s Service is terminated for Cause, the Option shall terminate in its entirety and cease to be exercisable immediately upon such termination of Service. 

v Other Termination of Service. If the Participant’s Service terminates for any reason, except Disability, death or Cause, the
Option, to the extent unexercised and exercisable for vested shares on the date on which the Participant’s Service terminated, may be exercised by the Participant at any time prior to the expiration of three (3) months after the date on
which the Participant’s Service terminated, unless a longer exercise period is provided by the Board, but in any event no later than the Option Expiration Date. 

vi Extension if Exercise Prevented by Law. Notwithstanding the foregoing other than termination of Service for Cause, if the exercise
of an Option within the applicable time periods set forth in Section 6.3.c is prevented by the provisions of Section 11.2 below, the Option shall remain exercisable until the later of (i) thirty (30) days after the date such
exercise first would no longer be prevented by such provisions or (ii) the end of the applicable time period under Section 6.3.c, but in any event no later than the Option Expiration Date. 

d. Transferability of Options. During the lifetime of the Participant, an Option shall be exercisable only by the Participant or the
Participant’s guardian or legal representative. An Option shall not be subject in any manner to anticipation, alienation, sale, exchange, transfer, assignment, pledge, encumbrance, or garnishment by creditors of the Participant or the
Participant’s beneficiary, except transfer by will or by the laws of descent and distribution. 
 7. Restricted Stock Unit
Awards. 
 Restricted Stock Unit Awards shall be evidenced by Award Agreements in such form as the Board shall from time to time
establish. Award Agreements evidencing Restricted Stock Unit Awards may incorporate all or any of the terms of the Plan by reference and shall comply with and be subject to the following terms and conditions: 

7.1. Types of Restricted Stock Unit Awards Authorized. Restricted Stock Unit Awards may be granted upon such conditions as the
Board shall determine, including, without limitation, upon the attainment of one or more performance goals. 
 7.2. Number of
Shares. Each Award Agreement will specify the number of Shares and will provide for the adjustment of such number in accordance with Subsection 4.2 of the Plan. 

7.3. Purchase Price. The purchase price for Shares issuable under each Restricted Stock Unit Award, if any, shall be established
by the Board in its discretion. Except as may be required by applicable law or established by the Board, no monetary payment (other than applicable tax withholding) shall be required as a condition of receiving a Restricted Stock Unit Award. 

  
 12 

 7.4. Payment of Purchase Price. Except as otherwise provided below, payment of the
purchase price (if any) for the number of shares of Stock being purchased pursuant to any Restricted Stock Unit Award shall be made (a) in cash, by check or in cash equivalent, (b) by such other consideration as may be approved by the
Board from time to time to the extent permitted by applicable law, or (c) by any combination thereof. 
 7.5. Vesting and
Restrictions on Transfer. Shares issued pursuant to any Restricted Stock Unit Award may (but need not) be made subject to Vesting Conditions based upon the satisfaction of such Service requirements, conditions, restrictions or Performance
Goals, as shall be established by the Board and set forth in the Award Agreement evidencing such Award. The Board, in its discretion, may provide in any Award Agreement evidencing a Restricted Stock Unit Award that, if the satisfaction of Vesting
Conditions with respect to any shares subject to such Restricted Stock Unit Award would otherwise occur on a day on which the sale of such shares would violate the provisions of the Insider Trading Policy, then satisfaction of the Vesting Conditions
automatically shall be determined on the next trading day on which the sale of such shares would not violate the Insider Trading Policy. 

7.6. Settlement of Restricted Units; Procedure; Rights as a Shareholder. Any Restricted Stock Unit Award granted
hereunder will be settled according to the terms of the Plan and at such times and under such conditions as determined by the Board and set forth in the Award Agreement. Until the Restricted Stock Unit Awards are settled and the Shares are delivered
(as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote, if applicable, or receive dividends or any other rights as a shareholder will exist with respect to the
Award. No adjustment will be made for a dividend or other right for which the record date is prior to the date the Shares are delivered, except as provided in Section 4.2 of the Plan or the applicable Award Agreement. 

7.7. Nontransferability of Restricted Stock Unit Award Rights. Rights to acquire Shares pursuant to a Restricted Stock Unit
Award shall not be subject in any manner to anticipation, alienation, sale, exchange, transfer, assignment, pledge, encumbrance or garnishment by creditors of the Participant or the Participant’s beneficiary, except transfer by will or the laws
of descent and distribution. All rights with respect to a Restricted Stock Unit Award granted to a Participant hereunder shall be exercisable during his or her lifetime only by such Participant or the Participant’s guardian or legal
representative. 
 7.8. Cessation of Services. Each Award Agreement will specify the consequences of a Participant’s
ceasing to be a Service Provider prior to the settlement of a Restricted Stock Unit Award. 
 8. Performance-Based Awards.

 8.1. General. If the Board, in its discretion, decides to grant an Award intended to qualify as “performance-based
compensation,” the provisions of this Section 8 will control over any contrary provision in the Plan. 

  
 13 

 8.2. Performance Goals. The granting and/or vesting of Awards and other incentives under
the Plan may, in the discretion of the Board, be made subject to the achievement of one or more Performance Goals. 
 8.3.
Procedures. The Board will, in writing, (i) designate one or more Participants to whom an Award will be made, (ii) determine the Performance Period, (iii) establish the Performance Goals and amounts that may be earned for the
Performance Period, and (iv) determine any other terms and conditions applicable to the Award(s). 
 8.4. Determination of Amounts
Earned. Following the completion of each Performance Period, the Board will certify in writing whether the applicable Performance Goals have been achieved for such Performance Period. A Participant will be eligible to receive payment pursuant to
an Award intended to qualify as “performance-based compensation” for a Performance Period only if the Performance Goals for such period are achieved. In determining the amounts earned by a Participant pursuant to an Award intended to be
qualified as “performance-based compensation,” the Board will have the right to (a) reduce or eliminate (but not to increase) the amount payable at a given level of performance to take into account additional factors that the Board
may deem relevant to the assessment of individual or corporate performance for the Performance Period, (b) determine what actual Award, if any, will be paid in the event of a termination of employment as the result of a Participant’s death
or disability or upon a Change of Control or in the event of a termination of employment following a Change of Control prior to the end of the Performance Period, and (c) determine what actual Award, if any, will be paid in the event of a
termination of employment other than as the result of a Participant’s death or Disability prior to a Change of Control and prior to the end of the Performance Period to the extent an actual Award would have otherwise been achieved had the
Participant remained employed through the end of the Performance Period. 
 9. Standard Forms of Award Agreements. 

9.1. Award Agreements. Each Award shall comply with and be subject to the terms and conditions set forth in the
appropriate form of Award Agreement approved by the Board and as amended from time to time. No Award or purported Award shall be a valid and binding obligation of the Company unless evidenced by a fully executed Award Agreement. Any Award Agreement
may consist of an appropriate form of notice of the grant and a form of Award Agreement incorporated therein by reference, or such other form or forms, including electronic media, as the Board may approve from time to time. 

9.2. Authority to Vary Terms. The Board shall have the authority from time to time to vary the terms of any
standard form of Award Agreement either in connection with the grant or amendment of an individual Award or in connection with the authorization of a new standard form or forms; provided, however, that the terms and conditions of any such new,
revised or amended standard form or forms of Award Agreement are not inconsistent with the terms of the Plan. 

  
 14 

 10. Change in Control. 

10.1. Effect of Change in Control on Awards. The Board may provide for any one or more of the following: 

a. Accelerated Vesting. The Board may, in its discretion, provide in any Award Agreement or, in the event of a Change in
Control, may take such actions as it deems appropriate to provide for the acceleration of the exercisability and/or vesting in connection with such Change in Control of each or any outstanding Award or portion thereof and shares acquired pursuant
thereto upon such conditions, including termination of the Participant’s Service prior to, upon, or following such Change in Control, to such extent as the Board shall determine. 

b. Assumption, Continuation or Substitution of Awards. In the event of a Change in Control, the surviving, continuing,
successor, or purchasing corporation or other business entity or parent thereof, as the case may be (the “Acquiror”), may, without the consent of any Participant, assume or continue the Company’s rights and
obligations under each or any Award or portion thereof outstanding immediately prior to the Change in Control or substitute for each or any such outstanding Award or portion thereof a substantially equivalent award with respect to the
Acquiror’s shares. For purposes of this Section, if so determined by the Board, in its discretion, an Award or any portion thereof shall be deemed assumed if, following the Change in Control, the Award confers the right to receive, subject to
the terms and conditions of the Plan and the applicable Award Agreement, for each Share subject to such portion of the Award immediately prior to the Change in Control, the consideration (whether shares, cash, other securities or property or a
combination thereof) to which a holder of a Share on the effective date of the Change in Control was entitled; provided, however, that if such consideration is not solely common shares of the Acquiror, the Board may, with the consent of the
Acquiror, provide for the consideration to be received upon the exercise of the Award for each Share to consist solely of common shares of the Acquiror equal in Fair Market Value to the per share consideration received by holders of Shares pursuant
to the Change in Control. If any portion of such consideration may be received by holders of Shares pursuant to the Change in Control on a contingent or delayed basis, the Board may, in its discretion, determine such Fair Market Value per share as
of the time of the Change in Control on the basis of the Board’s good faith estimate of the present value of the probable future payment of such consideration. Any Award or portion thereof which is neither assumed or continued by the Acquiror
in connection with the Change in Control nor exercised as of the time of consummation of the Change in Control shall terminate and cease to be outstanding effective as of the time of consummation of the Change in Control. Notwithstanding the
foregoing, shares acquired upon exercise of an Award prior to the Change in Control and any consideration received pursuant to the Change in Control with respect to such shares shall continue to be subject to all applicable provisions of the Award
Agreement evidencing such Award except as otherwise provided in such Award Agreement. 
 c.
Cash-Out of Outstanding Awards. The Board may, in its discretion and without the consent of any Participant, determine that, upon the occurrence of a Change in Control, each or any Award or portion
thereof outstanding immediately prior to the Change in Control shall be canceled in exchange for a payment with respect to each vested Share (and each unvested Share, if so determined by the Board) subject to such canceled Award in (i)

  
 15 

 
cash, (ii) shares of the Company or of a corporation or other business entity a party to the Change in Control, or (iii) other property which, in any such case, shall be in an amount
having a Fair Market Value equal to the Fair Market Value of the consideration to be paid per Share in the Change in Control, reduced by the exercise or purchase price per share, if any, under such Award. If any portion of such consideration may be
received by holders of Shares pursuant to the Change in Control on a contingent or delayed basis, the Board may, in its sole discretion, determine such Fair Market Value per share as of the time of the Change in Control on the basis of the
Board’s good faith estimate of the present value of the probable future payment of such consideration. In the event such determination is made by the Board, the amount of such payment (reduced by applicable withholding taxes, if any) shall be
paid to Participants in respect of the vested portions of their canceled Awards as soon as practicable following the date of the Change in Control and in respect of the unvested portions of their canceled Awards in accordance with the vesting
schedules applicable to such Awards. 
 11. Tax Withholding. 

11.1. Tax Withholding in General. The Company shall have the right to deduct from any and all payments made under the Plan, or to
require the Participant, through payroll withholding, cash payment or otherwise, including by means of a Cashless Exercise of an Option, to make adequate provision for, the federal, state, local and foreign taxes (including any social insurance
tax), if any, required by law to be withheld by the Participating Company Group with respect to an Award or the shares acquired pursuant thereto. The Company shall have no obligation to deliver Shares or to release Shares from an escrow established
pursuant to an Award Agreement until the Participating Company Group’s tax withholding obligations have been satisfied by the Participant. 

11.2. Withholding in Shares. The Company shall have the right, but not the obligation, to deduct from the Shares issuable to a
Participant upon the exercise of an Award, or to accept from the Participant the tender of, a number of whole Shares having a Fair Market Value, as determined by the Company, equal to all or any part of the tax withholding obligations of the
Participating Company Group. The Fair Market Value of any Shares withheld or tendered to satisfy any such tax withholding obligations shall not exceed the amount determined by the applicable minimum statutory withholding rates. 

12. Compliance with Securities Law. 

The grant of Awards and the issuance of Shares pursuant to any Award shall be subject to compliance with all applicable requirements of
federal, state and foreign law with respect to such securities and the requirements of any stock exchange or market system upon which the Shares may then be listed. In addition, no Award may be exercised or shares issued pursuant to an Award unless
(a) a registration statement under the Securities Act shall at the time of such exercise or issuance be in effect with respect to the shares issuable pursuant to the Award or (b) the shares issuable pursuant to the Award may be issued in
accordance with the terms of an applicable exemption from the registration requirements of the Securities Act. The inability of the Company to obtain from any regulatory body having jurisdiction the authority, if any, deemed by the Company’s
legal counsel to be necessary to the lawful issuance and sale of any shares hereunder shall relieve the Company of any liability in respect of the failure to issue or 

  
 16 

 
sell such shares as to which such requisite authority shall not have been obtained. As a condition to issuance of any Shares, the Company may require the Participant to satisfy any qualifications
that may be necessary or appropriate, to evidence compliance with any applicable law or regulation and to make any representation or warranty with respect thereto as may be requested by the Company. 

13. Amendment or Termination of Plan. 

The Board may amend, suspend or terminate the Plan at any time. However, without the approval of the Company’s shareholders, there shall
be (a) no increase in the maximum aggregate number of Shares that may be issued under the Plan (except by operation of the provisions of Section 4.1), (b) no change in the class of persons eligible to receive Incentive Stock Options,
and (c) no other amendment of the Plan that would require approval of the Company’s shareholders under any applicable law, regulation or rule, including the rules of any stock exchange or market system upon which the Shares may then be
listed. No amendment, suspension or termination of the Plan shall affect any then outstanding Award unless expressly provided by the Board. Except as provided by the next sentence, no amendment, suspension or termination of the Plan may adversely
affect any then outstanding Award without the consent of the Participant. Notwithstanding any other provision of the Plan or any Award Agreement to the contrary, the Board may, in its sole and absolute discretion and without the consent of any
Participant, amend the Plan or any Award Agreement, to take effect retroactively or otherwise, as it deems necessary or advisable for the purpose of conforming the Plan or such Award Agreement to any present or future law, regulation or rule
applicable to the Plan. 
 14. Miscellaneous Provisions. 

14.1. Repurchase Rights. Shares issued under the Plan may be subject to a right of first refusal, one or more
repurchase options, or other conditions and restrictions as determined by the Board in its discretion at the time the Award is granted. The Company shall have the right to assign at any time any repurchase right it may have, whether or not such
right is then exercisable, to one or more persons as may be selected by the Company. Upon request by the Company, each Participant shall execute any agreement evidencing such transfer restrictions prior to the receipt of Shares hereunder and shall
promptly present to the Company any and all certificates representing Shares acquired hereunder for the placement on such certificates of appropriate legends evidencing any such transfer restrictions. 

14.2. Rights as Employee, Consultant or Director. No person, even though eligible pursuant to Section 4.2, shall have a
right to be selected as a Participant, or, having been so selected, to be selected again as a Participant. Nothing in the Plan or any Award granted under the Plan shall confer on any Participant a right to remain an Employee, Consultant or Director
or interfere with or limit in any way any right of a Participating Company to terminate the Participant’s Service at any time. To the extent that an Employee of a Participating Company other than the Company receives an Award under the Plan,
that Award shall in no event be understood or interpreted to mean that the Company is the Employee’s employer or that the Employee has an employment relationship with the Company. 

  
 17 

 14.3. Rights as a Shareholder. A Participant shall have no rights as a shareholder
with respect to any shares covered by an Award until the date of the issuance of such shares (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company). No adjustment shall be made for
dividends, distributions or other rights for which the record date is prior to the date such shares are issued, except as provided in Section 4.1 or another provision of the Plan. In addition, any rights that a Participant has with respect to
any Shares issued under any Award shall be subject to the terms and conditions of any shareholder agreement adopted by the Company. No Shares shall be issued pursuant to an Award unless the recipient of such Shares has executed a joinder to the
shareholders agreement, if any. 
 14.4. Delivery of Title to Shares. Subject to any governing rules or regulations, the
Company shall issue or cause to be issued the Shares acquired pursuant to an Award and shall deliver such shares to or for the benefit of the Participant by means of one or more of the following: (a) by delivering to the Participant evidence of
book entry Shares credited to the account of the Participant, (b) by depositing such Shares for the benefit of the Participant with any broker with which the Participant has an account relationship, or (c) by delivering such Shares to the
Participant in certificate form. 
 14.5. Fractional Shares. The Company shall not be required to issue fractional shares upon
the exercise or settlement of any Award. 
 14.6. Retirement and Welfare Plans. Neither Awards made under this Plan nor Shares
or cash paid pursuant to such Awards shall be included as “compensation” for purposes of computing the benefits payable to any Participant under any Participating Company’s retirement plans (both qualified and non-qualified) or welfare benefit plans unless such other plan expressly provides that such compensation shall be taken into account in computing such benefits. 

14.7. Section 409A of the Code. Notwithstanding other provisions of the Plan or any Award Agreements
hereunder, no Award shall be granted, deferred, accelerated, extended, paid out or modified under this Plan in a manner that would result in the imposition of an additional tax under Section 409A of the Code upon a Participant. In the event
that it is reasonably determined by the Board or, if delegated by the Board to the Committee, by the Committee that, as a result of Section 409A of the Code, payments in respect of any Award under the Plan may not be made at the time
contemplated by the terms of the Plan or the relevant Award Agreement, as the case may be, without causing the Participant holding such Award to be subject to taxation under Section 409A of the Code, including as a result of the fact that the
Participant is a “specified employee” under Section 409A of the Code, the Company will make such payment on the first day that would not result in the Participant incurring any tax liability under Section 409A of the Code. The
Company shall use commercially reasonable efforts to implement the provisions of this Section 14.7 in good faith; provided that neither the Company, the Board nor any of the Company’s employees, directors or representatives shall have any
liability to Participants with respect to this Section 14.7. 
 14.8. Severability. If any one or more of the provisions
(or any part thereof) of this Plan shall be held invalid, illegal or unenforceable in any respect, such provision shall be 

  
 18 

 
modified so as to make it valid, legal and enforceable, and the validity, legality and enforceability of the remaining provisions (or any part thereof) of the Plan shall not in any way be
affected or impaired thereby. 
 14.9. No Constraint on Corporate Action. Nothing in this Plan shall be construed to: (a) limit,
impair, or otherwise affect the Company’s or another Participating Company’s right or power to make adjustments, reclassifications, reorganizations, or changes of its capital or business structure, or to amalgamate, merge or consolidate,
or dissolve, liquidate, sell, or transfer all or any part of its business or assets; or (b) limit the right or power of the Company or another Participating Company to take any action which such entity deems to be necessary or appropriate. 

14.10. Choice of Law. The validity, interpretation, construction and performance of the Plan and each Award Agreement shall be governed
by the laws of the laws of the United States of America, without regard to its conflict of law rules. 

  
 19

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00275-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00275-of-00352.parquet"}]]